Centinel Spine’s Stalif Line Wins Expanded Indication

Centinel Spine’s stand-alone No-Profile integrated interbody fusion device has gained an expanded indication for multilevel, cervical spine fusion procedures.

Previously, the Stalif product line had been cleared for use in conjunction with autograft or allogenic bone graft surgeries for degenerative disc disease, the West Chester, Pa., devicemaker said Tuesday.

Centinel Spine was founded in 2008 from the merger of Raymedica and Surgicraft. — Jason Scott